Gsk (GSK) Change in Account Payables (2009 - 2023)

Gsk (GSK) has 8 years of Change in Account Payables data on file, last reported at -$18.6 million in Q4 2023.

• For the quarter ending Q4 2023, Change in Account Payables changed N/A year-over-year to -$18.6 million; the trailing twelve-month figure through Dec 2023 stood at $388.6 million (changed N/A YoY), and the FY2023 full-year result was -$18.7 million, down 103.05% from the prior year.
• Change in Account Payables was -$18.6 million for Q4 2023 at Gsk, down from $60.7 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of -$18.6 million in Q4 2023 to a low of -$18.6 million in Q4 2023.